Anterior Pituitary

  • William H. Daughaday


The pituitary gland and its peptide hormones continue to attract intense investigative interest. This review makes no pretense of including all clinical and research papers in the field. Difficulty is encountered in the classification of papers. Many papers dealing with the pituitary are better considered in sections dealing with the hypothalamus and others in sections dealing with regulation of the function of the various target hormones. Because prolactin and growth hormone do not act on endocrine target glands, they have received more attention. The newer developments in our knowledge of the somatomedins and other growth-hormone-dependent growth factors are reviewed in some detail. The subjects discussed in any review reflect the interests and prejudices of the author. Greater representation by articles from the Journal of Clinical Endocrinology and Metabolism reflects the personal association of the author with that journal.


Growth Hormone Luteinizing Hormone Pituitary Tumor Anterior Pituitary Acromegalic Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Mains, R.E., Eipper, B.A., and ling, N., 1977, Common precursor to corticotropins and endorphins, Proc. Natl. Acad. Sci. U.S.A. 74: 3014–3018.PubMedCrossRefGoogle Scholar
  2. 2.
    Orth, D.N., and Nicholson, W.E., 1977, High molecular weight forms of human ACTH are glycoproteirts, J. Clin. Endocrinol. Metab. 44: 214–217.PubMedCrossRefGoogle Scholar
  3. 3.
    Bachelot, I., Wolfsen, A.R., and Odell, W.D., 1977, Pituitary and plasma lipotropins: Demonstration of the artifactual nature of βMSH, J. Clin. Endocrinol. Metab. 44: 939–946.PubMedCrossRefGoogle Scholar
  4. 4.
    Gilkes, J.J.H., Rees, L.H., and Besser, G.M., 1977, Plasma immunoreactive corticotrophin and lipotrophin in Cushing’s syndrome and Addison’s disease, B. Med. J. 1: 996–998.CrossRefGoogle Scholar
  5. 5.
    Guillemin, R., Vargo, T., Rossier, J., Minick, S., ling, N., Rivier, C., Vale, W., and Bloom, F., 1977, β-Endorphin and adrenocorticotropin are secreted concomitantly by the pituitary gland, Science 197: 1367–1369.PubMedCrossRefGoogle Scholar
  6. 6.
    Bertagna, X., Donnadieu, M., Idatte, J.-M., and Girard, F., 1977, Dynamics and characterization of plasma immunoreactive β-melanocyte stimulating hormone in hemodialysis patients: Its relationship to ACTH, J. Clin. Endocnnol. Metab. 45: 1179–1186.CrossRefGoogle Scholar
  7. 7.
    Krieger, D.T., and Luria, M., 1977, Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in Cushing’s disease and Nelson’s syndrome, J. Clin. Endocrinol. Metab. 44: 361–368.PubMedCrossRefGoogle Scholar
  8. 8.
    Matsukura, S., Kakita, T., Hirata, Y., Yoshimi, H., Fukase, M., Iwasaki, Y., Kato, Y., and Imura, H., 1977, Adenylate cyclase of GH and ACTH producing tumors of human: Activation by non-specific hormones and other bioactive substances, J. Clin. Endocrinol. Metab. 44: 392–397.PubMedCrossRefGoogle Scholar
  9. 9.
    Fehm, H.L., Voigt, K.H., Land, R.E., Beinert, K.E., Kummer, G.W., and Pfeiffer, E.F., 1977, Paradoxical ACTH response to glucocorticoids in Cushing’s disease, N. Engl. J. Med. 297: 904–907.PubMedCrossRefGoogle Scholar
  10. 10.
    Moore, T.J., Dluhy, R.G., Williams, G.H., and Cain, J.P., 1976, Nelson’s syndrome: Frequency, prognosis, and effect of prior pituitary irradiation, Ann. Intern. Med. 85: 731–734.PubMedGoogle Scholar
  11. 11.
    Hopwood, N.J., and Kenny, F.M., 1977, Incidence of Nelson’s syndrome after adrenalectomy for Cushing’s disease in children, Am. J. Dis. Child. 131: 1353–1356.PubMedGoogle Scholar
  12. 12.
    Jennings, A.S., Liddle, G.W., and Orth, D.N., 1977, Results of treating childhood Cushing’s disease with pituitary irradiation, N. Engl. J. Med. 297: 957–962.PubMedCrossRefGoogle Scholar
  13. 13.
    Carmalt, M.H.B., Dalton, G.A., Fletcher, R.F., and Smith, W.T., 1977, The treatment of Cushing’s disease by trans-sphenoidal hypophysectomy, Q.J. Med. 46: 119–134.PubMedGoogle Scholar
  14. 14.
    Salassa, R.M., Laws, E.R., Carpenter, P.C., and Northcutt, R.C., 1978, Transsphenoidal removal of pituitary microadenoma in Cushing’s disease, Mayo Clin. Proc. 53: 24–28.PubMedGoogle Scholar
  15. 15.
    Gewirtz, G., and Yalow, R.S., 1974, Ectopic ACTH production in carcinoma of the lung, J. Clin. Invest. 53: 1022–1032.PubMedCrossRefGoogle Scholar
  16. 16.
    Odell, W., Wolfsen, A., Yoshimoto, Y., Weitzman, R., Fisher, D., and Hirose, F., 1977, Ectopic peptide synthesis: A universal concomitant of neoplasia, Trans. Assoc. Am. Physicians 90: 204–227.PubMedGoogle Scholar
  17. 17.
    Bloomfield, G.A., Holdaway, I.M., Corrin, B., Ratcliffe, J.G., Rees, G.M., Ellison, M., and Rees, L.H., 1977, Lung tumours and ACTH production, Clin. Endocrinol. 6: 95–104.CrossRefGoogle Scholar
  18. 18.
    Himsworth, R.L., Bloomfield, G.A., Coombes, R.C., Ellison, M., Gilkes, J.J.H., Lowry, P.J., Setchell, K.D.R., Slavin, G., and Rees, L.H., 1977, “Big ACTH” and calcitonin in an ectopic hormone secreting tumour of the liver, Clin. Endocrinol. 7: 45–61.CrossRefGoogle Scholar
  19. 19.
    Krieger, D.T., and Gewirtz, G.P., 1974, The nature of the circadian periodicity and suppressibility of immunoreactive ACTH levels in Addison’s disease, J. Clin. Endocrinol. Metab. 39: 46–52.PubMedCrossRefGoogle Scholar
  20. 20.
    Clayton, R., Schrieber, V., Burden, A.C., and Rosenthal, F.D., 1977, Secondary pituitary hyperplasia in Addison’s disease, Lancet 2: 954–956.PubMedCrossRefGoogle Scholar
  21. 21.
    Desaulles, P.A., Riniker, B., and Rittel, W., 1969, High corticotrophic activity of a short chain synthetic corticotrophin analogue, in: Protein and Polypeptide Hormones (M. Margoulies, ed.), pp. 489–491, Excerpta Medica, Amsterdam.Google Scholar
  22. 22.
    Jeffcoate, W.J., Phenekos, C., Ratcliffe, J.G., Williams, S., Rees, L., and Besser, G.M., 1977, Comparison of the pharmacokinetics in man of two synthetic ACTH analogues: α1–24 and substituted α1–18 ACTH, Clin. Endocrinol. 7: 1–11.CrossRefGoogle Scholar
  23. 23.
    Sandman, C.A., George J., McCanne, T.R., Nolan, J.D., Kaswan, J., and Kastin, A.J., 1977, MSH/ACTH 4–10 influences behavioral and physiological measures of attention, J. Clin. Endocrinol. Metab. 44: 884–891.PubMedCrossRefGoogle Scholar
  24. 24.
    Mullin, B.R., Aloj, S.M., Fishman, P.H., Lee, G., Kohn, L.D., and Brady, R.O., 1976, Cholera toxin interactions with thyrotropin receptors on thyroid plasma membranes, Proc. Natl. Acad. Sci. U.S.A. 73: 1679–1683.PubMedCrossRefGoogle Scholar
  25. 25.
    Mullin, B.R., Fishman, P.H., Lee, G., Aloj, S.M., Ledley, F.D., Winand, R.J., Kohn, L.D., and Brady, R.O., 1976, Thyrotropin-ganglioside interactions and their relationship to the structure and function of thyrotropin receptors, Proc. Natl. Acad. Sci. U.S.A. 73: 842–846.PubMedCrossRefGoogle Scholar
  26. 26.
    Mullin, B.R., Pacuszka, T., Lee, G., Kohn, L.D., Brady, R.O., and Fishman, P.H., 1978, Thyroid gangliosides with high affinity for thyrotropin: Potential role in thyroid regulation, Science 199: 77–79.PubMedCrossRefGoogle Scholar
  27. 27.
    Ledley, F.D., Mullin, B.R., Lee, G., Aloj, S.M., Fishman, P.H., Hunt, L.T., Dayhoff, M.O., and Kohn, L.D., 1976, Sequence similarity between cholera toxin and glycoprotein hormones: Implications for structure activity relationship and mechanism of action, Biochem. Biophys. Res. Commun. 69: 852–859.PubMedCrossRefGoogle Scholar
  28. 28.
    Erhardt, F.W., and Scriba, P.C., 1977, High molecular thyrotrophin (“big”-TSH) from human pituitaries: Preparation and partial characterization, Acta Endocrinol. 85: 698–712.PubMedGoogle Scholar
  29. 29.
    Larsen, P.R., and Frumess, R.D., 1977, Comparison of the biological effects of thyroxine and triiodothyronine in the rat, Endocrinology 100: 980–988.PubMedCrossRefGoogle Scholar
  30. 30.
    Silva, J.E., and Larsen, P.R., 1977, Pituitary nuclear 3,5,3′-triiodothyronine and thyrotropin secretion: An explanation for the effect of thyroxine, Science 198: 617–620.PubMedCrossRefGoogle Scholar
  31. 31.
    Carlson, H.E., and Brickman, A.S., 1977, Effect of hypocalcemia on hormonal responses to thyrotropin-releasing hormone, J. Clin. Endocrinol. Metab. 45: 209–214.PubMedCrossRefGoogle Scholar
  32. 32.
    Croxson, M.S., Hall, T.D., Kletzky, O.A., Jaramillo, J.E., and Nicoloff, J.T., 1977, Decreased serum thyrotropin induced by fasting, J. Clin. Endocrinol. Metab. 45: 560–568.PubMedCrossRefGoogle Scholar
  33. 33.
    Delitala, G., Rovasio, P., and Lotti, G., 1977, Suppression of thyrotropin (TSH) and prolactin (PRL) release by pyridoxine in chronic primary hypothyroidism, J. Clin. Endocrinol. Metab. 45: 1019–1022.PubMedCrossRefGoogle Scholar
  34. 34.
    Samaan, N.A., Osborne, B.M., Mackay, B., Leavens, M.E., Duello, T.M., and Halmi, N.S., 1977, Endocrine and morphologic studies of pituitary adenomas secondary to primary hypothyroidism, J. Clin. Endocrinol. Metab. 45: 903–911.PubMedCrossRefGoogle Scholar
  35. 35.
    Kourides, I.A., Ridgway, E.C., Weintraub, B.D., Bigos, S.T., Gershengorn, M.C., and Maloof, F., 1977, Thyrotropin-induced hyperthyroidism: Use of alpha and beta subunit levels to identify patients with pituitary tumors, J. Clin. Endocrinol. Metab. 45: 534–543.PubMedCrossRefGoogle Scholar
  36. 36.
    Amir, S.M., Uchimura, H., and Ingbar, S.H., 1977, Interactions of bovine thyrotropin and preparations of human chorionic gonadotropin with bovine thyroid membranes, J. Clin. Endocrinol. Metab. 45: 280–292.PubMedCrossRefGoogle Scholar
  37. 37.
    Boyd, A.E., III, and Sanchez-Franco, F., 1977, Changes in the prolactin response to thyrotropin-releasing hormone (TRH) during the menstrual cycle of normal women, J. Clin. Endocrinol. Metab. 44: 985–989.PubMedCrossRefGoogle Scholar
  38. 38.
    Sowers, J.R., Carlson, H.E., Brautbar, N., and Hershman, J.M., 1977, Effect of dexamethasone on prolactin and TSH responses to TRH and metoclopramide in man, J. Clin. Endocrinol. Metab. 44: 237–241.PubMedCrossRefGoogle Scholar
  39. 39.
    Cooper, D.S., and Jacobs, L.S., 1977, Apomorpine inhibits the prolactin but not the TSH response to thyrotropin releasing hormone, J. Clin. Endocrinol. Metab. 44: 404–407.PubMedCrossRefGoogle Scholar
  40. 40.
    Besses, G.S., Burrow, G.N., Spaulding, S.W., and Donabedian, R.K., 1975, Dopamine infusions acutely inhibit the TSH and prolactin response to TRH, J. Clin. Endocrinol. Metab. 41: 985–988.PubMedCrossRefGoogle Scholar
  41. 41.
    Beitins, I.Z., Lipson, L.G., and McArthur, J.W., 1977, Immunoreactive luteinizing hormone, follicle stimulating hormone and their subunits in tissue culture media from normal and adenomatous, human pituitary fragments, J. Clin. Endocrinol. Metab. 45: 1271–1280.PubMedCrossRefGoogle Scholar
  42. 42.
    Weintraub, B.D., Stannard, B.S., and Rosen, S.W., 1977, Combination of ectopic and standard human glycoprotein hormone alpha with beta sub-units: Discordance of immunologic and receptor-binding activity, Endocrinology 101: 225–235.PubMedCrossRefGoogle Scholar
  43. 43.
    Prentice, L.G., and Ryan, R.J., 1975, LH and its subunits in human pituitary serum and urine, J. Clin. Endocrinol. Metab. 40: 303–312.PubMedCrossRefGoogle Scholar
  44. 44.
    Reichert, L.E., Jr., and Ramsey, R.B., 1977, Evidence for the existence of a large molecular weight protein in human pituitary tissue having follicle stimulating hormone activity, J. Clin. Endocrinol. Metab. 44: 545–552.PubMedCrossRefGoogle Scholar
  45. 45.
    Bahl, O.P., 1977, Human chorionic gonadotropin, its receptor and mechanism of action, Fed. Proc. Fed. Am. Soc. Exp. Biol. 36: 2119–2127.Google Scholar
  46. 46.
    Beitins, I.Z., Derfel, R.L., O’Loughlin, K., and McArthur, J.W., 1977, Immunoreactive luteinizing hormone, follicle stimulating hormone and their subunits in human urine following gel filtration, J. Clin. Endocrinol. Metab. 44: 149–159.PubMedCrossRefGoogle Scholar
  47. 47.
    Hoff, J.D., Lasley, B.L., Wang, C.F., and Yen, S.S.C., 1977, The two pools of pituitary gonadotropin: Regulation during the menstrual cycle, J. Clin. Endocnnol. Metab. 44: 302–312.CrossRefGoogle Scholar
  48. 48.
    Jewelewicz, R., Dyrenfurth, I., Ferin, M., Bogumil, J., and Vande Wiele, R.L., 1977, Gonadotropin, estrogen and progesterone response to long term gonadotropin-releasing hormone infusion at various stages of the menstrual cycle, J. Clin. Endocrinol. Metab. 45: 662–667.PubMedCrossRefGoogle Scholar
  49. 49.
    Penny, R., Olambiwonnu, N.O., and Frasier, S.D., 1977, Episodic fluctuations of serum gonadotropins in pre-and post-pubertal girls and boys, J. Clin. Endocrinol. Metab. 45: 307–311.PubMedCrossRefGoogle Scholar
  50. 50.
    Penny, R., Goldstein, I.P., and Frasier, S.D., 1977, Overnight gonadotropin secretion in normal females, J. Clin. Endocrinol. Metab. 44: 780–783.PubMedCrossRefGoogle Scholar
  51. 51.
    Reiter, E.O., Root, A.W., and Duckett, G.E., 1977, LH and FSH levels in urine and serum of prepubertal and pubertal children receiving a 3 hour infusion of LH-RH, J. Clin. Endocrinol. Metab. 44: 56–61.PubMedCrossRefGoogle Scholar
  52. 52.
    Santner, S.J., Kulin, H.E., and Santen, R.J., 1977, Usefulness of urinary gonadotropin measurements to assess luteinizing releasing factor (LRF) responsiveness in hypogonadotropic states, J. Clin. Endocrinol. Metab. 44: 313–321.PubMedCrossRefGoogle Scholar
  53. 53.
    Lucky, A.W., Rebar, R.W., Blizzard, R.M., and Goren, E.M., 1977, Pubertal progression in the presence of elevated serum gonadotropins in girls with multiple endocrine deficiencies, J. Clin. Endocrinol. Metab. 45: 673–678.PubMedCrossRefGoogle Scholar
  54. 54.
    Cunningham, G.R., and Huckins, C., 1977, An FSH and prolactin-secreting pituitary tumor: Pituitary dynamics and testicular histology, J. Clin. Endocnnol. Metab. 44: 248–253.CrossRefGoogle Scholar
  55. 55.
    Demura, R., Kubo, O., Demura, H., and Shizume, K., 1977, FSH and LH secreting pituitary adenoma, J. Clin. Endocrinol. Metab. 45: 653–657.PubMedCrossRefGoogle Scholar
  56. 56.
    Baker, B.L., and Yu, Y.-Y., 1977, An immunocytochemical study of human pituitary mammotropes from fetal life to old age, Am. J. Anat. 148: 217–240.PubMedCrossRefGoogle Scholar
  57. 57.
    Vekemans, M., Delvoye, P., L’Hermite, M., and Robyn, C., 1977, Serum prolactin levels during the menstrual cycle, J. Clin. Endocrinol. Metab. 44: 989–993.PubMedCrossRefGoogle Scholar
  58. 58.
    Rigg, L.A., and Yen, S.S.C., 1977, Multiphasic prolactin secretion during parturition in human subjects, Am. J. Obstet. Gynecol. 128: 215–218.PubMedGoogle Scholar
  59. 59.
    Woolf, P.D., Lee, L.A., Leebaw, W., Thompson, D., Iilavivathana, U., Brodows, R., and Campbell, R., 1977, Intracellular glucopenia causes prolactin release in man, J. Clin. Endocrinol. Metab. 45: 377–383.PubMedCrossRefGoogle Scholar
  60. 60.
    Delvoye, P., Delogne-Desnoeck, J., Uwayitu-Nyampeta, and Robyn, C., 1977, Time-course of physiological hyperprolactinaemia during two years lactation, Clin. Endocrinol. 7: 257–259.CrossRefGoogle Scholar
  61. 61.
    Franks, S., Nabarro, J.D.N., and Jacobs, H.S., 1977, Prevalence and presentation of hyperprolactinaemia in patients with “functioniess” pituitary tumors, Lancet 1: 778–780.PubMedCrossRefGoogle Scholar
  62. 62.
    Baumann, G., Marynick, S.P., Winters, S.J., and Loriaux, D.L., 1977, The effect of osmotic stimuli on prolactin secretion and renal water excretion in normal man and in chronic hyperprolactinemia, J. Clin. Endocrinol. Metab. 44: 199–202.PubMedCrossRefGoogle Scholar
  63. 63.
    Holland, O.B., Gomez-Sanchez, C.E., Kern, D.C., Weinberger, M.H., Kramer, N.J., and Higgins, J.R., 1977, Evidence against prolactin stimulation of aldosterone in normal human subjects and patients with primary aldosteronism, including a patient with a primary aldosteronism and a prolactin-producing pituitary microadenoma, J. Clin. Endocrinol. Metab. 45: 1064–1076.PubMedCrossRefGoogle Scholar
  64. 64.
    Turkington, R.W., Majumder, G.C., Kadohama, N., MacIndoe, J.H., and Frantz, W.L., 1973, Hormonal regulation of gene expression in mammalian cells, Recent Prog. Horm. Res. 29: 417–455.PubMedGoogle Scholar
  65. 65.
    Witorsch, R.J., and Kitay, J.I., 1972, Pituitary hormones affecting adrenal 5α-reductase activity: ACTH, growth hormone and prolactin, Endocrinology 91: 764–769.PubMedCrossRefGoogle Scholar
  66. 66.
    Forbes, A.P., Henneman, P.H., Griswold, G.C., and Albright, F., 1954, Syndrome characterized by galactorrhea, amenorrhea and low urinary FSH: Comparison with acromegaly and normal lactation, J. Clin. Endocrinol. Metab. 14: 265–271.PubMedCrossRefGoogle Scholar
  67. 67.
    Varma, M.M., Huseman, C.A., Johanson, A.J., and Blizzard, R.M., 1977, Effect of prolactin on adrenocortical and gonadal function in normal men, J. Clin. Endocrinol. Metab. 44: 760–762.PubMedCrossRefGoogle Scholar
  68. 68.
    Feldman, J.M., and Plonk, J.W., 1978, Effect of hyperprolactinemia on pituitary-adrenal function, Horm. Res. 9: 1–11.PubMedCrossRefGoogle Scholar
  69. 69.
    Vermeulen, A., Suy, E., and Rubens, R., 1977, Effect of prolactin on plasma DHEA(S) levels, J. Clin. Endocrinol. Metab. 44: 1222–1225.PubMedCrossRefGoogle Scholar
  70. 70.
    Bassi, F., Giusti, G., Borsi, L., Cattaneo, S., Giannotti, P., Forti, G., Pazzagli, M., Vigiani, C., and Serio, M., 1977, Plasma androgens in women with hyperprolactinaemic amenorrhoea, Clin. Endocrinol. 6: 5–10.CrossRefGoogle Scholar
  71. 71.
    Carter, J.N., Tyson, J.E., Warne, G.L., McNeilly, A.S., Faiman, C., and Friesen, H.G., 1977, Adrenocortical function in hyperprolactinemic women, J. Clin. Endocrinol. Metab. 45: 973–980.PubMedCrossRefGoogle Scholar
  72. 72.
    Parker, L.N., Sack, J., Fisher, D.A., and Odell, W D., 1978, The adrenarche: Prolactin, gonadotropins, adrenal androgens, and cortisol, J. Clin. Endocnnol Metab. 46: 396–401.CrossRefGoogle Scholar
  73. 73.
    Wiebe, R.H., Handwerger, S., and Hammond, C.B., 1977, Failure of l-tryptophan to stimulate prolactin secretion in man, J. Clin. Endocrinol. Metab. 45: 1310–1312.PubMedCrossRefGoogle Scholar
  74. 74.
    Lancranjan, I., Wirz-Justice, A., Puhringer, W., and Del Pozo, E., 1977, Effect of 1–5 hydroxytryptophan infusion on growth hormone and prolactin secretion in man, J. Clin. Endocrinol. Metab. 45: 588–593.PubMedCrossRefGoogle Scholar
  75. 75.
    Egge, A.C., Rogol, A.D., Varma, M.M., and Blizzard, R.M., 1977, Effect of cyproheptadine on TRH-stimulated prolactin and TSH release in man, J. Clin. Endocrinol. Metab. 44: 210–213.PubMedCrossRefGoogle Scholar
  76. 76.
    Burrow, G.N., May, P.B., Spaulding, S.W., and Donabedian, R.K., 1977, TRH and dopamine interactions affecting pituitary hormone secretion, J. Clin. Endocrinol. Metab. 45: 65–72.PubMedCrossRefGoogle Scholar
  77. 77.
    Fonzo, D., Angeli, A., Sivieri, R., Andriolo, S., Frajria, R., and Ceresa, F., 1977, Hyperprolactinemia in girls with idiopathic precocious puberty under prolonged treatment with cyproterone acetate, J. Clin. Endocrinol. Metab. 45: 164–168.PubMedCrossRefGoogle Scholar
  78. 78.
    Morley, J.E., Dawson, M., Hodgkinson, H., and Kalk, W.J., 1977, Galactorrhea and hyperprolactinemia associated with chest wall injury, J. Clin. Endocrinol. Metab. 45: 931–935.PubMedCrossRefGoogle Scholar
  79. 79.
    Ramirez, G., O’Neill, W.M., Jr., Bloomer, H.A., and Jubiz, W., 1977, Abnormalities in the regulation of prolactin in patients with chronic renal failure, J. Clin. Endocrinol. Metab. 45: 658–661.PubMedCrossRefGoogle Scholar
  80. 80.
    Yamaji, T., Shimamoto, K., Kosaka, K., and Isurugi, K., 1977, Heterogeneity of prolactin and TSH response to TRH in hypogonadotropic hypogonadism, J. Clin. Endocrinol. Metab. 45: 319–323.PubMedCrossRefGoogle Scholar
  81. 81.
    Spitz, I.M., Almaliach, U., Rosen, E., Polishuk, W., and Rabinowitz, D., 1977, Dissociation of prolactin responsiveness to TRH and chlorpromazine in women with isolated gonadotropin deficiency, J. Clin. Endocrinol. Metab. 45: 1173–1178.PubMedCrossRefGoogle Scholar
  82. 82.
    Spitz, I.M., Landau, H., Almaliach, U., Rosen, E., Brautbar, N., and Russell, A., 1977, Diminished prolactin reserve: A case report, J. Clin. Endocrinol. Metab. 45: 412–418.PubMedCrossRefGoogle Scholar
  83. 83.
    Onishi, T., Miyai, K., Aono, T., Shioji, T., Yamamoto, T., Okada, Y., and Kumahara, Y., 1977, Primary hypothyroidism and galactorrhea, Am. J. Med. 63: 373–378.PubMedCrossRefGoogle Scholar
  84. 84.
    Healy, D.L., Pepperell, R.J., Stockdale, J., Bremner, W.J., and Burger, H.G., 1977, Pituitary autonomy in hyperprolactinemic secondary amenorrhea: Results of hypothalamic-pituitary testing, J. Clin. Endocrinol. Metab. 44: 809–819.PubMedCrossRefGoogle Scholar
  85. 85.
    Seppälä, M., Lehtovirta, P., and Ranta, T., 1977, Discordant patterns of hyperprolactinaemia and galactorrhoea in secondary amenorrhoea, Acta Endocrinol. 86: 457–463.PubMedGoogle Scholar
  86. 86.
    Kletzky, O.A., Davajan, V., Mishell, D.R., Jr., Nicoloff, J., Mims, R., March, C.M., and Nakamura, R.M., 1977, A sequential pituitary stimulation test in normal subjects and in patients with amenorrhea-galactorrhea with pituitary tumors, J. Clin. Endocrinol. Metab. 45: 631–640.PubMedCrossRefGoogle Scholar
  87. 87.
    Lachelin, G.C.L., Abu-Fadil, S., and Yen, S.S.C., 1977, Functional delineation of hyperprolactinemic-amenorrhea, J. Clin. Endocrinol. Metab. 44: 1163–1174.PubMedCrossRefGoogle Scholar
  88. 88.
    Board, J.A., Fierro, R.J., Wasserman, A.J., and Bhatnagar, A.S., 1977, Effects of α-and β-adrenergic blocking agents on serum prolactin levels in women with hyperprolactinemia and galactorrhea, Am. J. Obstet. Gynecol. 127: 285–287.PubMedGoogle Scholar
  89. 89.
    Van Meter, Q.L., Gareis, F.J., Hayes, J.W., and Wilson, C.B., 1977, Galactorrhea in a 12-year-old boy with a chromophobe adenoma, J. Pediatr. 90: 756–759.PubMedCrossRefGoogle Scholar
  90. 90.
    Koenig, M.P., Zuppinger, K., and Iiechti, B., 1977, Hyperprolactinemia as a cause of delayed puberty: Successful treatment with bromocriptine, J. Clin. Endocrinol. Metab. 45: 825–828.PubMedCrossRefGoogle Scholar
  91. 91.
    Strauch, G., Valcke, J.C., Mahoudeau, J.A., and Bricaire, H., 1977, Hormonal changes induced by bromocriptine (CB-154) at the early stage of treatment, J. Clin. Endocrinol. Metab. 44: 588–590.PubMedCrossRefGoogle Scholar
  92. 92.
    Lamberts, S.W.J., Seldenrath, H.J., Kwa, H.G., and Birkenhager, J.C., 1977, Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine, J. Clin. Endocrinol. Metab. 44: 180–184.PubMedCrossRefGoogle Scholar
  93. 93.
    Foukas, M.D., 1973, An antilactogenic effect of pyridoxine, J. Obstet. Gynaecol. Br. Commonw. 80: 718–720.PubMedCrossRefGoogle Scholar
  94. 94.
    McIntosh, E.N., 1976, Treatment of women with the galactorrhea-amenorrhea syndrome with pyridoxine (vitamin B6), J. Clin. Endocrinol. Metab. 42: 1192–1195.PubMedCrossRefGoogle Scholar
  95. 95.
    Tolis, G., Laliberte, R., Guyda, H., and Naftolin, F., 1977, Ineffectiveness of pyridoxine (B6) to alter secretion of growth hormone and prolactin and absence of therapeutic effects on galactorrhea-amenorrhea syndromes, J. Clin. Endocrinol. Metab. 44: 1197–1199.PubMedCrossRefGoogle Scholar
  96. 96.
    Seeburg, P.R., Shine, J., Martial, J., Baxter, J.D., and Goodman, H.M., 1978, Structure and purification of human growth hormone (hGH) gene sequences, Clin. Res. 26: 427A.Google Scholar
  97. 97.
    Bieler, E.U., Pitout, M.J., Stroud, S.W., and van Rooyen, R.J., 1977, Conversion of monomeric human growth hormone and big growth hormone into different molecular weight forms in vitro and after injection into humans, Horm. Res. 8: 29–36.PubMedCrossRefGoogle Scholar
  98. 98.
    Heymsfield, S.B., Bethel, R.A., Hall, E.C., Mills, J.B., Moseley, M.H., Kostyo, J.L., and Rudman, D., 1977, Anabolic actions of reduced and S-carbamidomethylated human growth hormone and its plasmin digest in man, J. Clin. Invest. 60: 563–570.PubMedCrossRefGoogle Scholar
  99. 99.
    Moore, W.V., and Leppert, P., 1977, Binding of native and reduced carbamidomethylated hGH to rabbit liver plasma membranes, J. Clin. Endocrinol. Metab. 45: 569–575.PubMedCrossRefGoogle Scholar
  100. 100.
    Lesniak, M.A., Gorden, P., and Roth, J., 1977, Reactivity of non-primate growth hormones and prolactins with human growth hormone receptors on cultured human lymphocytes, J. Clin. Endocrinol. Metab. 44: 838–849.PubMedCrossRefGoogle Scholar
  101. 101.
    Carr, D., and Friesen, H.G., 1976, Growth hormone and insulin binding to human liver, J. Clin. Endocrinol. Metab. 42: 484–493.PubMedCrossRefGoogle Scholar
  102. 102.
    Golde, D.W., Bersch, N., and Li, C.H., 1977, Growth hormone: Species-specific Stimulation of erythropoiesis in vitro, Science 196: 1112–1113.PubMedCrossRefGoogle Scholar
  103. 103.
    Ledet, T., 1976, Growth hormone stimulating the growth of arterial medial cells in vitro: Absence of effect of insulin, Diabetes 25: 1011–1017.PubMedCrossRefGoogle Scholar
  104. 104.
    Merimee, T.J., and Pulkkinen, A.J., 1977, GH-estrogen interaction in modulating insulin secretion, J. Clin. Endocrinol. Metab. 45: 232–235.PubMedCrossRefGoogle Scholar
  105. 105.
    Heymsfield, S.B., Bethel, R.A., and Rudman, D., 1977, Hyperresponsiveness of patients with clinical and premyopathic myotonic dystrophy to human growth hormone, J. Clin. Endocrinol. Metab. 45: 147–158.PubMedCrossRefGoogle Scholar
  106. 106.
    Aloia, J.F., Zanzi, I., Vaswani, A., Ellis, K., and Cohn, S.H., 1977, Combination therapy for osteoporosis, Metabolism 26: 787–792.PubMedCrossRefGoogle Scholar
  107. 107.
    Lancranjan, I., and Marbach, P., 1977, New evidence for growth hormone modulation by the α-adrenergic system in man, Metabolism 26: 1225–1230.PubMedCrossRefGoogle Scholar
  108. 108.
    LaRossa, J.T., Agrin, R., and Melby, J.C., 1977, Apomorphine-stimulated growth hormone release, Am. J. Med. 63: 909–913.CrossRefGoogle Scholar
  109. 109.
    Caraceni, T., Panerai, A.E., Parati, E.A., Cocchi, D., and Muller, E.E., 1977, Altered growth hormone and prolactin responses to dopaminergic stimulation in Huntington’s chorea, J. Clin. Endocrinol. Metab. 44: 870–875.PubMedCrossRefGoogle Scholar
  110. 110.
    Delitala, G., Devilla, L., Bionda, S., and Franca, V., 1977, Suppression of human growth hormone secretion by cyproheptadine, Metabolism 26: 931–936.PubMedCrossRefGoogle Scholar
  111. 111.
    Lal, S., Guyda, H., and Bikadoroff, S., 1977, Effect of methysergide and pimozide on apomorphine-induced growth hormone secretion in men, J. Clin. Endocrinol. Metab. 44: 766–770.PubMedCrossRefGoogle Scholar
  112. 112.
    Miyabo, S., Asato, T., and Mizushima, N., 1977, Prolactin and growth hormone responses to psychological stress in normal and neurotic subjects, J. Clin. Endocrinol. Metab. 44: 947–951.PubMedCrossRefGoogle Scholar
  113. 113.
    Tenore, A., Berman, W.F., Parks, J.S., and Bongiovanni, A.M., 1977, Basal and stimulated serum growth hormone concentrations in inflammatory bowel disease, J. Clin. Endocrinol. Metab. 44: 622–628.PubMedCrossRefGoogle Scholar
  114. 114.
    Collu, R., Leboeuf, G., Letarte, J., and Ducharme, J.-R., 1977, Increase in plasma growth hormone levels following thyrotropin-releasing hormone injection in children with primary hypothyroidism, J. Clin. Endocrinol. Metab. 44: 743–747.PubMedCrossRefGoogle Scholar
  115. 115.
    Zanoboni, A., and Zanoboni-Muciaccia, W., 1977, Elevated basal growth hormone levels and growth hormone response to TRH in alcoholic patients with cirrhosis, J. Clin. Endocrinol. Metab. 45: 576–578.PubMedCrossRefGoogle Scholar
  116. 116.
    Panerai, A.E., Salerno, F., Manneschi, M., Cocchi, D., and Muller, E.E., 1977, Growth hormone and prolactin responses to thyrotropin-releasing hormone in patients with severe liver disease, J. Clin. Endocrinol. Metab. 45: 134–140.PubMedCrossRefGoogle Scholar
  117. 117.
    Blundell, T.L., Bedarkar, S., Rinderknecht, E., and Humbel, R.E., 1978, Insulin-like growth factor: A model for tertiary structure accounting for immunoreactivity and receptor binding, Proc. Natl. Acad. Sci. U.S.A. 75: 180–184.PubMedCrossRefGoogle Scholar
  118. 118.
    Chochinov, R.H., Mariz, I.K., and Daughaday, W.H., 1977, Isolation of a somatomedin from plasma of rats bearing growth hormone secreting tumors, Endocrinology 100: 549–556.PubMedCrossRefGoogle Scholar
  119. 119.
    Canalis, E.M., Hintz, R.L., Dietrich, J.W., Maina, D.M., and Raisz, L.G., 1977, Effect of somatomedin and growth hormone on bone collagen synthesis in vitro, Metabolism 26: 1079–1087.PubMedCrossRefGoogle Scholar
  120. 120.
    Dehnel, J.M., and Hamblen, D.L., 1977, Influence of oxygen tension on somatomedin activity in vitro, J. Endocrinol. 72: 361–369.PubMedCrossRefGoogle Scholar
  121. 121.
    Rechler, M.M., Podskalny, J.M., and Nissley, S.P., 1977, Characterization of the binding of multiplication-stimulating activity to a receptor for growth polypeptides in chick embryo fibroblasts, J. Biol. Chem. 252: 3898–3910.PubMedGoogle Scholar
  122. 122.
    Rechler, M.M., Nissley, S.P., Podskalny, J.M., Moses, A.C., and Fryklund, L., 1977, Identification of a receptor for somatomedin-like polypeptides in human fibroblasts, J. Clin. Endocrinol. Metab. 44: 820–831.PubMedCrossRefGoogle Scholar
  123. 123.
    Hollenberg, M.D., and Fryklund, L., 1977, Insulin and somatomedin A and B: Comparison of biological activities in cultured human skin-derived fibroblasts, Life Sci. 21: 943–950.PubMedCrossRefGoogle Scholar
  124. 124.
    Thorsson, A.V., and Hintz, R.L., 1977, Specific 125I-somatomedin receptor on circulating human mononuclear cells, Biochem. Biophys. Res. Commun. 74: 1566–1573.PubMedCrossRefGoogle Scholar
  125. 125.
    Kaufmann, U., Zapf, J., Torretti, B., and Froesch, E.R., Demonstration of a specific serum carrier protein of nonsuppressible insulin-like activity in vivo, J. Clin. Endocrinol. Metab. 44: 160–166.Google Scholar
  126. 126.
    Hintz, R.L., and Liu, F., 1977, Demonstration of specific plasma protein binding sites for somatomedin, J. Clin. Endocrinol. Metab. 45: 988–995.PubMedCrossRefGoogle Scholar
  127. 127.
    Chochinov, R.H., Mariz, I.K., Hajek, A.S., and Daughaday, W.H., 1977, Characterization of a protein in mid-term human amniotic fluid which reacts in the somatomedin-C radioreceptor assay, J. Clin. Endocrinol. Metab. 44: 902–908.PubMedCrossRefGoogle Scholar
  128. 128.
    D’Ercole, J., Underwood, L.E., and Van Wyk, J.J., 1977, Serum somatomedin-C in hypopituitarism and in other disorders of growth, J. Pediatr. 90: 375–381.PubMedCrossRefGoogle Scholar
  129. 129.
    Furlanetto, R.W., Underwood, L.E., Van Wyk, J.J., and D’Ercole, A.J., 1977, Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay, J. Clin. Invest. 60: 648–657.PubMedCrossRefGoogle Scholar
  130. 130.
    Megyesi, K., Gorden, P., and Kahn, C.R., 1977, Lack of a simple relationship between endogenous growth hormone and NSILA-s related peptides, J. Clin. Endocrinol. Metab. 45: 330–338.PubMedCrossRefGoogle Scholar
  131. 131.
    Hyodo, T., Megyesi, K., Kahn, C.R., McLean, J.P., and Friesen, H.G., 1977, Adrenocortical carcinoma and hypoglycemia: Evidence for production of nonsuppressible insulin-like activity by the tumor, J. Clin. Endocrinol. Metab. 44: 1175–1184.PubMedCrossRefGoogle Scholar
  132. 132.
    Hoffenberg, R., Howell, A., Epstein, S., Pimstone, B.L., Fryklund, L., Hall, K., Schwalbe, S., and Rudd, B.T., 1977, Increasing growth with raised circulating somatomedin but normal immunoassayable growth hormone, Clin. Endocrinol. 6: 443–448.CrossRefGoogle Scholar
  133. 133.
    Phillips, L.S., and Young, H.S., 1976, Nutrition and somatomedin. II. Serum somatomedin activity and cartilage growth activity in streptozotocin-diabetic rats, Diabetes 25: 516–527.PubMedCrossRefGoogle Scholar
  134. 134.
    Cohen, M.P., Jasti, K., and Rye, D.L., 1977, Somatomedin in insulin-dependent diabetes mellitus, J. Clin. Endocrinol. Metab. 45: 236–239.PubMedCrossRefGoogle Scholar
  135. 135.
    Takano, K., Hizuka, N., Shizume, K., Hayashi, N., Motoike, Y., and Obata, H., 1977, Serum somatomedin peptides measured by somatomedin A radioreceptor assay in chronic liver disease, J. Clin. Endocrinol. Metab. 45: 828–832.PubMedCrossRefGoogle Scholar
  136. 136.
    Daughaday, W.H., 1977, Extreme gigantism, N. Engl. J. Med. 297: 1267–1269.PubMedCrossRefGoogle Scholar
  137. 137.
    Strauch, G., Lego, A., Therain, F., and Bricaire, H., 1977, Reversible plasma and red blood cells volumes increases in acromegaly, Acta Endocrinol. 85: 465–478.PubMedGoogle Scholar
  138. 138.
    Daggett, P.R., and Nabarro, J.D.N., 1977, Measurement of the 4 hour integrated plasma concentration of growth hormone in assessing the response of acromegalic patients to treatment, Clin. Endocrinol. 7: 437–441.CrossRefGoogle Scholar
  139. 139.
    Lawrence, A.M., Gordon, D.L., Hagen, T.C., and Schwartz, M.A., 1977, Hypothalamic hypopituitarism after pituitary apoplexy in acromegaly, Arch. Intern. Med. 137: 1134–1137.PubMedCrossRefGoogle Scholar
  140. 140.
    Cryer, P.E., and Daughaday, W.H., 1977, Adrenergic modulation of growth hormone secretion in acromegaly: Alpha-and beta-adrenergic blockade produce qualitatively normal responses but no effect on L-dopa suppression, J. Clin. Endocrinol. Metab. 44: 977–979.PubMedCrossRefGoogle Scholar
  141. 141.
    Camanni, F., Massara, F., Belforte, L., Rosatello, A., and Molinatti, G.M., 1977, Effect of dopamine on plasma growth hormone and prolactin levels in normal and acromegalic subjects, J. Clin. Endocrinol. Metab. 44: 465–473.PubMedCrossRefGoogle Scholar
  142. 142.
    Takahara, J., Yakushiji, W., Yamauchi, J., Miyoshi, M., Hosogi, H., and Ofuji, T., 1977, Transient appearance of a provocative growth hormone response to l-dopa following incomplete adenomectomy in an acromegalic patient, J. Clin. Endocrinol. Metab. 44: 599–602.PubMedCrossRefGoogle Scholar
  143. 143.
    Nakagawa, K., and Obara, T., 1977, Failure of growth hormone-suppressing agents to affect TSH-releasing hormone-and LH-releasing hormone-induced growth hormone release in acromegaly, J. Clin. Endocrinol. Metab. 44: 189.PubMedCrossRefGoogle Scholar
  144. 144.
    Ishibashi, M., Yamaji, T., and Kosaka, K., 1977, Effect of bromoergocriptine on TRH-induced growth hormone and prolactin release in acromegalic patients, J. Clin. Endocrinol. Metab. 45: 275–279.PubMedCrossRefGoogle Scholar
  145. 145.
    Cassar, J., Mashiter, K., and Joplin, G.F., 1977, Bromocriptine treatment of acromegaly, Metabolism 26: 539–546.PubMedCrossRefGoogle Scholar
  146. 146.
    Belforte, L., Camanni, F., Chiodini, P.G., Liuzzi, A., Massara, F., Molinatti, G.M., Muller, E.E., and Silvestrini, F., 1977, Long-term treatment with 2-Br-α-ergocryptine in acromegaly, Acta Endocrinol. 85: 235–248.PubMedGoogle Scholar
  147. 147.
    Schwinn, G., Dirks, H., McIntosh, C., and Kobberling, J., 1977, Metabolic and clinical studies on patients with acromegaly treated with bromocriptine over 22 months, Eur. J. Clin. Invest. 7: 101–107.PubMedCrossRefGoogle Scholar
  148. 148.
    Chihara, K., Kato, Y., Abe, H., Furumoto, M., Maeda, K., and Imura, H., 1977, Sleep-related growth hormone release following 2-bromo-α-ergocriptine treatment in acromegalic patients, J. Clin. Endocrinol. Metab. 44: 78–84.PubMedCrossRefGoogle Scholar
  149. 149.
    Rona, R.J., and Tanner, J.M., 1977, Aetiology of idiopathic growth hormone deficiency in England and Wales, Arch. Dis. Child. 52: 197–208.PubMedCrossRefGoogle Scholar
  150. 150.
    Howse, P.M., Rayner, P.H.W., Williams, J.W., Rudd, B.T., Bertrande, P.V., Thompson, C.R.S., and Jones, L.A., 1977, Nyctohemeral secretion of growth hormone in normal children of short stature and in children with hypopituitarism and intrauterine growth retardation, Clin. Endocrinol. 6: 347–359.CrossRefGoogle Scholar
  151. 151.
    Schonberger, W., Grimm, W., and Ziegler, R., 1977, The effect of Nacom (l-dopa and l-carbidopa) on growth hormone secretion in 75 patients with short stature, Eur. J. Pediatr. 127: 15–19.PubMedCrossRefGoogle Scholar
  152. 152.
    Preece, M.A., and Tanner, J.M., 1977, Results of intermittent treatment of growth hormone deficiency with human growth hormone, J. Clin. Endocrinol. Metab. 45: 169–170.PubMedCrossRefGoogle Scholar
  153. 153.
    Frasier, S.D., Aceto, T., Jr., Hayles, A.B., and Mikity, V.G., 1977, Collaborative study of the effects of human growth hormone in growth hormone deficiency. IV. Treatment with low doses of human growth hormone based on body weight, J. Clin. Endocrinol. Metab. 44: 22–31.PubMedCrossRefGoogle Scholar
  154. 154.
    Lee, H.B., and Faiman, C., 1977, Isolated thyrotropin deficiency due to a pituitary tumor, Can. Med. Assoc. J. 116: 520–521.PubMedGoogle Scholar
  155. 155.
    Weber, F.T., Donnelly, W.H., Jr., and Bejar, R.L., 1977, Hypopituitarism following extirpation of a pharyngeal pituitary, Am. J. Dis. Child. 131: 525–528.PubMedGoogle Scholar
  156. 156.
    Rudman, D., Fleischer, A.S., Kutner, M.H., and Raggio, J.F., 1977, Suprahypophyseal hypogonadism and hypothyroidism during prolonged coma after head trauma, J. Clin. Endocrinol. Metab. 45: 747–754.PubMedCrossRefGoogle Scholar
  157. 157.
    Olson, L.D., and Winternitz, W.W., 1977, Hypopituitarism: A complication of diabetes, South. Med. J. 70: 411–413.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1979

Authors and Affiliations

  • William H. Daughaday
    • 1
  1. 1.Metabolism Division, Department of MedicineWashington University School of MedicineSt. LouisUSA

Personalised recommendations